Portugal

 

Lusiadas deal still on as seller carries cost of muti-million fine

The planned acquisition of Lusiadas Saude, Portugal's third largest hospital group, by France's third largest hospital group Vivalto Sante, will not be impacted by the €34.2m fine that has been handed to Lusiadas by Portugal's competition authority.
August 18, 2022

KKR may switch to private credit to finance IVI RMA takeover

Facing an increasingly volatile market, American buyout / investment firm KKR may switch to direct lenders to finance its acquisition of fertility company IVI RMA Global, despite agreeing €800m of underwritten financing from four investment banks.
August 18, 2022

Portuguese hospital groups face €191 million fine

The Autorldade da Concorrencia (AdC), the Portuguese Competition Authority, has sanctioned and imposed fines of €191 million on several private hospital groups and the Portuguese Private Hospitals Association (APHP).
July 18, 2022

Vivalto Sante goes international with expansion into Portugal and Switzerland

Vivalto Sante, the third largest for-profit hospital group in France, is joining the likes of Fresenius, Ramsay and Mediclinic as it becomes the latest member of the highly select club of multinational hospital groups. As well as having bought a chain of three clinics in Switzerland, it is buying Lusiadas Saude, the third largest hospital group in Portugal. CEO Daniel Caille tells HBI that the decision to go international has nothing to do with opportunities for consolidation within the French market drying up.
July 8, 2022

Warsaw hub model set to spread across CEE

A new Warsaw Health Innovation Hub in Poland has seen 30 big pharma and medtech contribute brains and money to tackle healthcare projects, extending the cooperation which developed during Covid between the government and the private sector. Healthcare providers are set to join. The model is likely to be adopted by other CEE countries.
May 26, 2022

Lusiadas Saude sale latest

HBI hears that there has been progress in the sale of Lusiadas Saude, Portugal’s third-largest hospital group by revenue.
May 5, 2022

Affidea deal – underbidders and EBITDA

HBI hears that the surprise buyer of European imaging and cancer treatment provider Affidea, Groupe Bruxelles Lambert (GBL) may not have been the highest bidder, despite winning out. HBI considers who else was in the running, and the EBITDA figure that may have been used for the deal.
April 28, 2022

Affidea bought by Groupe Bruxelles Lambert

Groupe Bruxelles Lambert (“GBL”) has signed definitive agreements to acquire a majority stake in European imaging and cancer treatment provider Affidea from B-FLEXION, the private investment firm of the Switzerland-based billionaire Bertarelli family. GBL will invest up to €1bn of equity for the transaction which is its first substantive healthcare investment.
April 19, 2022
Newer posts
Older posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us